Related Articles
Blood‑based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer‑risk stratification
miR-20b-5p is a novel biomarker for detecting prostate cancer
Upregulation of miR-146a by YY1 depletion correlates with delayed progression of prostate cancer
Correlation of the expression of YY1 and Fas cell surface death receptor with apoptosis of peripheral blood mononuclear cells, and the development of multiple organ dysfunction in children with sepsis
Progression of prostate cancer: Diagnostic and prognostic utility of prostate-specific antigen, α2-macroglobulin, and their complexes